Decision

UK REACH authorisation for Siemens Healthcare Diagnostics Products Ltd, 16 November 2021

Decision on application for authorisation under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 30 November 2021

Documents

UK REACH authorisation: Siemens Healthcare decision report

PDF, 132 KB, 8 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on a transitional application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).

Authorised use

Use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) as a detergent in the production of bead components for in-vitro diagnostic kits for an immunoassay platform.

Holder of the authorisation and authorisation number

Siemens Healthcare Diagnostics Products Ltd (UKREACH/21/04/0).

Date of decision

16 November 2021

Published 30 November 2021